Astec LifeSciences Limited (ASTEC) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Astec LifeSciences Limited stock ₹421, price ₹553, that is 23.9% below the price, quality 38 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Astec LifeSciences Limited
ASTEC · NSEExpensive (fair value 24% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range ₹521.85 – ₹2,248 · fair‑value band ₹315.72 – ₹526.20 · the ₹553.40 price screens above the ₹420.96 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Astec LifeSciences is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India.
Show moreShow less
The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives.
It also provides herbicides, insecticides, and specialty chemical products. The company also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited operates as a subsidiary of Godrej Agrovet Limited.
Stock analysis
Astec LifeSciences Limited (ASTEC) currently trades at ₹553.40, while our estimate is ₹420.96, 24% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₹315.72 (bear) to ₹526.20 (bull), the price of ₹553.40 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Astec LifeSciences Limited reported revenue of ₹4.5B in FY2026 versus ₹6.8B in FY2022, a compound −9.8%/yr. Reported net income was −₹809M in FY2026.
Key figures
Market cap ₹12.3B (≈ $131M) Micro · P/S ratio 2.95 · EPS (TTM) ₹−35.71 · Net margin −18.1% · Return on equity −21.2% · Return on assets (EBIT) −0.8% (5-year average) · Operating margin −41.8% · Revenue (TTM) ₹4.4B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 40% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 10% fair-value upside, at −24%, ASTEC screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
ASTEC screens overvalued: fair value 24% below the price. Compare with Nutrien Ltd →
Compare Astec LifeSciences Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 175 stocks
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Materials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| The Mosaic Company MOS | $21.23 | $28.58 | +35% | vs ASTEC |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥29.91 | ¥38.01 | +27% | vs ASTEC |
| Qinghai Salt Lake Industry Co 000792 | ¥21.62 | ¥26.81 | +24% | vs ASTEC |
| Nutrien Ltd NTR | $68.94 | $83.09 | +21% | vs ASTEC |
| ICL Group ICL | $4.41 | $4.86 | +10% | vs ASTEC |
| Yara International ASA YAR | kr 405.70 | kr 424.51 | +5% | vs ASTEC |
| CF Industries Holdings CF | $119.85 | $114.88 | −4% | vs ASTEC |
| UPL Limited UPL | ₹563.45 | ₹478.29 | −15% | vs ASTEC |
| Yunnan Yuntianhua Co 600096 | ¥26.06 | ¥17.67 | −32% | vs ASTEC |
| Coromandel International Limited COROMANDEL | ₹1,969 | ₹1,129 | −43% | vs ASTEC |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Astec LifeSciences Limited (ASTEC) overvalued or undervalued?
What is the fair value of ASTEC?
What is the quality score of ASTEC?
What is the price target for Astec LifeSciences Limited (ASTEC)?
What is the Astec LifeSciences Limited stock forecast for 2026?
What is the revenue of Astec LifeSciences Limited (ASTEC)?
What is the intrinsic value of Astec LifeSciences Limited (ASTEC)?
Is Astec LifeSciences Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of ASTEC?
How much is Astec LifeSciences Limited worth?
What do the bullish and bearish scenarios say about ASTEC?
How solid is the balance sheet of Astec LifeSciences Limited (ASTEC)?
How far is ASTEC from its 52-week high?
Which stocks are comparable to Astec LifeSciences Limited?
Is Astec LifeSciences Limited stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Astec LifeSciences Limited (ASTEC)?
What should I pay attention to with Astec LifeSciences Limited right now?
Key figures of Astec LifeSciences Limited
How large is the market capitalisation of Astec LifeSciences Limited (ASTEC)?
What is the P/S ratio of Astec LifeSciences Limited (ASTEC)?
What are the earnings per share of Astec LifeSciences Limited (ASTEC)?
What is the net margin of Astec LifeSciences Limited (ASTEC)?
What is the return on equity of Astec LifeSciences Limited (ASTEC)?
What is the EBIT return on assets of Astec LifeSciences Limited (ASTEC)?
What is the operating margin of Astec LifeSciences Limited (ASTEC)?
How fast is revenue growing at Astec LifeSciences Limited (ASTEC)?
How fast are earnings growing at Astec LifeSciences Limited (ASTEC)?
How much free cash flow does Astec LifeSciences Limited (ASTEC) generate?
How much net debt does Astec LifeSciences Limited (ASTEC) carry?
Watch Astec LifeSciences Limited in the live analysis
One click puts Astec LifeSciences Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.